1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. BGI Genomics Co., Ltd.
  6. Company
    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-14
61.16 CNY   -1.62%
07/29BGI Genomics Forms Medical Testing JV With Tibbiyah in Saudi Arabia
MT
07/27EXCLUSIVE : EU antitrust regulators likely to block Illumina, Grail deal - sources
RE
07/27Illumina offers patent licences to rivals, patent truce with BGI - sources
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
BGI Genomics Co. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Number of employees : 4 333 people.
Sales per Business
20202021Delta
Integrated Solutions for Precision Medical Testing5 562.2966.2%3 382.1250% -39.2%
Reproductive Health Basic Research and Clinical Application1 177.9014%1 192.4917.6% +1.24%
Infection Prevention and Control Basic Research and Clinical Application669.578%1 158.4117.1% +73.01%
Multi-omics Big Data Service and Synthetic625.927.5%641.599.5% +2.5%
Tumor Prevention and Control and Translational Medicine351.244.2%379.785.6% +8.12%
Other10.310.1%11.750.2% +13.96%
CNY in Million
Sales per region
20202021Delta
China (Excluding Hong Kong, Macau and Taiwan)2 798.3933.3%2 884.5842.6% +3.08%
Asia (Including Hong Kong, Macau and Taiwan) and Oceania3 776.6045%2 510.6737.1% -33.52%
Europe and Africa989.7011.8%938.7513.9% -5.15%
Americas832.559.9%432.136.4% -48.1%
CNY in Million
Managers
Name Title Age Since
Ye Yin General Manager & Director 42 -
Qian Xu Secretary 37 -
Du Yutao, Dr. Executive Vice President - -
Members of the board
Name Title Age Since
Jian Hua Wang Chairman 67 -
Song Gang Li Chairman-Supervisory Board 74 -
Ai Min Xu, Dr. Independent Director 54 -
Yu Hui Wu, Dr. Independent Director 43 -
Jun Wang Director 45 -
Ye Yin General Manager & Director 42 -
Hong Tao Wang Director 47 -
Ying Jun Sun Director 50 -
Peng Hui Chen Director 49 -
Wen Qi Li Member-Supervisory Board 35 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 419,914,466 216,195,351 51.5% 6,000,141 1.4% 51.5%
Shareholders
NameEquities%
Jian Hua Wang 153,590,467 58.7%
Jun Wang 34,470,455 13.2%
Wanjia Asset Management Co., Ltd. 15,708,531 6.00%
Shenzhen Heyu Gaolin Equity Investment LP 14,791,666 5.65%
Tianjin Liren Enterprise Management Consulting Co. Ltd. 4,037,106 1.54%
BGI Genomics Co. Ltd. ESOP 4,000,000 1.53%
E Fund Management Co., Ltd. 3,314,087 1.27%
Hwabao WP Fund Management Co., Ltd. 3,276,793 1.25%
Qian Xing He 2,820,936 1.08%
BGI Genomics Co., Ltd. 2,711,024 1.04%
Holdings
NameEquities%Valuation
BGI GENOMICS CO., LTD. (300676) 2,711,024 1.04% 24,956,603 USD
LIAONING HE EYE HOSPITAL GROUP CO., LTD. 1,065,173 1.15% 5,756,536 USD
Markets and indexes
- ChiNext
- SZSE 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  300676.SZ
- Datastream Code :  
Company contact information
BGI Genomics Co., Ltd.
Building NO.7, BGI Park 21 Hongan 3rd Street
CN-GD 518083 Shenzhen, Guangdong

Phone : +86 755 36307065
Fax :
web site : https://www.bgi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of BGI Genomics Co., Ltd.